Table 3 Univariate analysis of overall survival in patients with renal cell carcinoma.
From: Lower mean platelet volume predicts poor prognosis in renal cell carcinoma
Hazard ratio | 95% CI | P-value | |
|---|---|---|---|
Age (years) (≥60 versus <60) | 1.552 | 1.018–2.366 | 0.041 |
Gender (male versus female) | 1.287 | 0.836–1.981 | 0.251 |
Smoker (yes versus no) | 1.400 | 0.793–2.472 | 0.246 |
Drinking (yes versus no) | 0.789 | 0.290–2.149 | 0.643 |
BMI (kg/m2) | 0.956 | 0.899–1.017 | 0.150 |
FPG (mmol/L) | 1.081 | 0.969–1.207 | 0.162 |
WBC (×109/L) | 1.061 | 0.975–1.154 | 0.170 |
Hemoglobin (g/dl) | 0.977 | 0.968–0.986 | <0.001 |
Platelet count (×109/L) | 1.006 | 1.004–1.007 | <0.001 |
MPV (fL) (≤7.5 versus >7.5) | 2.513 | 1.657–3.812 | <0.001 |
Tumor size (cm) | |||
(>4.0 versus ≤4.0) | 2.312 | 1.457–3.669 | <0.001 |
Histology | |||
(Others versus Clear cell) | 2.300 | 0.844–6.268 | 0.103 |
Fuhrman grade | |||
(G3+G4 versus G1+G2) | 1.163 | 0.759–1.781 | 0.489 |
T classification | |||
(T3+T4 versus T1+T2) | 4.543 | 2.596–7.950 | <0.001 |
Lymph node metastasis | |||
(Present versus Absent) | 4.792 | 2.802–8.194 | <0.001 |
Distant metastasis | |||
(Present versus Absent) | 2.659 | 1.335–5.296 | 0.005 |
Microvascular invasion | |||
(Present versus Absent) | 2.357 | 1.477–3.762 | <0.001 |
TNM stage | |||
(III/IV versus I/II) | 4.985 | 3.193–7.782 | <0.001 |
ECOG PS | |||
(≥1 versus 0) | 2.078 | 1.303–3.315 | 0.002 |
